Captor Therapeutics S.A.
CTX | WAR
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Captor Therapeutics is a biopharmaceutical company focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome". Captor Therapeutics is a Swiss-Polish company. Captor GmbH entity operates in Basel, the pharma hub of Switzerland, providing excellent opportunities for business development, while our state-of-the-art laboratories are located in Wroclaw, Poland. Our integrated competencies and expertise in biology and chemistry allow us to perform all stages of early drug development.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 17:18 |
Board/Management Change
oświadczenie
|
Polish | 205.4 KB | |
| 2025-06-26 17:18 |
Proxy Solicitation & Information Statements
życiorys (PL)
|
Polish | 164.7 KB | |
| 2025-06-26 17:18 |
Board/Management Change
życiorys
|
English | 175.3 KB | |
| 2025-06-26 17:18 |
Declaration of Voting Results & Voting Rights Announcements
treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie
|
Polish | 469.4 KB | |
| 2025-06-26 17:18 |
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie 26 czerwca 2025 r., p…
|
Polish | 1.6 KB | |
| 2025-06-13 18:46 |
Proxy Solicitation & Information Statements
oświadczenie kandydata
|
Polish | 205.4 KB | |
| 2025-06-13 18:46 |
Company Presentation
życiorys zawodowy kandydata_PL (tłumaczenie maszynowe)
|
Polish | 164.7 KB | |
| 2025-06-13 18:46 |
Company Presentation
życiorys zawodowy kandydata
|
English | 175.3 KB | |
| 2025-06-13 18:46 |
Proxy Solicitation & Information Statements
zgłoszenie kandydatury wraz z projektem uchwały
|
Polish | 241.8 KB | |
| 2025-06-13 18:46 |
Board/Management Change
Zgłoszenie kandydata na członka Rady Nadzorczej Spółki - Content (PL)
|
Polish | 1020 bytes | |
| 2025-05-30 19:45 |
Declaration of Voting Results & Voting Rights Announcements
załącznik nr 9 - informacja o ogólnej liczbie głosów
|
Polish | 129.2 KB | |
| 2025-05-30 19:45 |
Declaration of Voting Results & Voting Rights Announcements
załącznik nr 8 - wzór instrukcji wykonywania prawa głosu przez pełnomocnika
|
Polish | 270.2 KB | |
| 2025-05-30 19:45 |
Proxy Solicitation & Information Statements
załącznik nr 7 - wzór pełnomocnictwa
|
Polish | 87.3 KB | |
| 2025-05-30 19:45 |
Corporate Governance Report
załącznik nr 6 - sprawozdanie Rady Nadzorczej Spółki za rok 2024
|
Polish | 829.9 KB | |
| 2025-05-30 19:45 |
Remuneration Report
załącznik nr 5 - raport niezależnego biegłego rewidenta z wykonania usługi dają…
|
Polish | 404.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |